Mylan Considering Takeover of Sweden's Meda -FT

US generic drug make Mylan (NYSE: MYL) is mulling a bid for Sweden's Meda, according to Financial Times. Sources report Mylan has hired adivsors to help put together a deal, which would create a $23 billion pharmaceutical company.

View full article http://www.ft.com/intl/cms/s/0/24aababc-bb78-11e3-8d4a-00144feabdc0.html#axzz2xuU35ONe